Trial · NCT07186062
Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal Function
NCT07186062, Phase 4, Completed, Ain Shams University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal Function. Trials, record NCT07186062. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07186062
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal Function
- NCT number
- NCT07186062
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 60 participants, actual
- Lead sponsor
- Ain Shams University
- Conditions
- Acute Decompensated Heart Failure (ADHF), Cardiorenal Syndrome (CRS)
- Interventions
- Levosimendan, Dobutamine, Milrinone
- First posted
- 2025-09-22
- Last updated
- 2026-09-21
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | renal function parameters. | 7 days | Changes in serum creatinine (mg/dl). Pre- and post-infusion values were compared to assess treatment response. |
| Primary | renal function | 7 days | Changes in serum BUN (mg/dl). Pre- and post-infusion values were compared to assess treatment response. |
| Primary | renal function | 7 days | Changes in eGFR (mL/min/1.73 m²). Pre- and post-infusion values were compared to assess treatment response. |
| Primary | renal function | 7 days | Changes in urine output (mL/day). Pre- and post-infusion values were compared to assess treatment response. |
| Primary | cardiac function | 7 days | changes in ejection fraction % by transthoracic echocardiography. Pre- and post-infusion values were compared to assess treatment response. |
| Primary | cardiac function | 7 days | Changes in cardiac index (L/min/m²) measured by EV1000 clinical platform device. Pre- and post-infusion values were compared to assess treatment response. |
| Primary | cardiac function | 7 days | changes in stroke volume variations (SVV) measured by EV1000 clinical platform. Pre- and post-infusion values were compared to assess treatment response. |
| Primary | cardiac function | 7 days | changes in systemic vascular resistance index (SVRI) using EV1000 clinical platform device. Pre- and post-infusion values were compared to assess treatment response. |
| Secondary | morbidity | 28 day | length of ICU stay (days). |
| Secondary | morbidity | 28 day | Total hospital stay (days) |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07186062
GET https://conductscience.org/api/trials/v1/NCT07186062/registered